166 related articles for article (PubMed ID: 35300306)
1. Solubility prediction in the bRo5 chemical space: where are we right now?
Ermondi G; Poongavanam V; Vallaro M; Kihlberg J; Caron G
ADMET DMPK; 2020; 8(3):207-214. PubMed ID: 35300306
[TBL] [Abstract][Full Text] [Related]
2. Updating the portfolio of physicochemical descriptors related to permeability in the beyond the rule of 5 chemical space.
Ermondi G; Vallaro M; Goetz G; Shalaeva M; Caron G
Eur J Pharm Sci; 2020 Apr; 146():105274. PubMed ID: 32088315
[TBL] [Abstract][Full Text] [Related]
3. Chamelogk: A Chromatographic Chameleonicity Quantifier to Design Orally Bioavailable Beyond-Rule-of-5 Drugs.
Garcia Jimenez D; Vallaro M; Rossi Sebastiano M; Apprato G; D'Agostini G; Rossetti P; Ermondi G; Caron G
J Med Chem; 2023 Aug; 66(15):10681-10693. PubMed ID: 37490408
[TBL] [Abstract][Full Text] [Related]
4. Cell permeability beyond the rule of 5.
Matsson P; Doak BC; Over B; Kihlberg J
Adv Drug Deliv Rev; 2016 Jun; 101():42-61. PubMed ID: 27067608
[TBL] [Abstract][Full Text] [Related]
5. Solution Conformations Explain the Chameleonic Behaviour of Macrocyclic Drugs.
Danelius E; Poongavanam V; Peintner S; Wieske LHE; Erdélyi M; Kihlberg J
Chemistry; 2020 Apr; 26(23):5231-5244. PubMed ID: 32027758
[TBL] [Abstract][Full Text] [Related]
6. Steering New Drug Discovery Campaigns: Permeability, Solubility, and Physicochemical Properties in the bRo5 Chemical Space.
Caron G; Kihlberg J; Goetz G; Ratkova E; Poongavanam V; Ermondi G
ACS Med Chem Lett; 2021 Jan; 12(1):13-23. PubMed ID: 33488959
[TBL] [Abstract][Full Text] [Related]
7. Managing Experimental 3D Structures in the Beyond-Rule-of-5 Chemical Space: The Case of Rifampicin.
Ermondi G; Lavore F; Vallaro M; Tiana G; Vasile F; Caron G
Chemistry; 2021 Jul; 27(40):10394-10404. PubMed ID: 34114271
[TBL] [Abstract][Full Text] [Related]
8. Conformational Sampling Deciphers the Chameleonic Properties of a VHL-Based Degrader.
Ermondi G; Jimenez DG; Rossi Sebastiano M; Kihlberg J; Caron G
Pharmaceutics; 2023 Jan; 15(1):. PubMed ID: 36678900
[TBL] [Abstract][Full Text] [Related]
9. Design Principles for Balancing Lipophilicity and Permeability in beyond Rule of 5 Space.
Möbitz H
ChemMedChem; 2024 Mar; 19(5):e202300395. PubMed ID: 37986275
[TBL] [Abstract][Full Text] [Related]
10. Stereochemistry Balances Cell Permeability and Solubility in the Naturally Derived Phepropeptin Cyclic Peptides.
Schwochert J; Lao Y; Pye CR; Naylor MR; Desai PV; Gonzalez Valcarcel IC; Barrett JA; Sawada G; Blanco MJ; Lokey RS
ACS Med Chem Lett; 2016 Aug; 7(8):757-61. PubMed ID: 27563399
[TBL] [Abstract][Full Text] [Related]
11. Refinement of Computational Access to Molecular Physicochemical Properties: From Ro5 to bRo5.
Rossi Sebastiano M; Garcia Jimenez D; Vallaro M; Caron G; Ermondi G
J Med Chem; 2022 Sep; 65(18):12068-12083. PubMed ID: 36094896
[TBL] [Abstract][Full Text] [Related]
12. Opportunities and guidelines for discovery of orally absorbed drugs in beyond rule of 5 space.
Poongavanam V; Doak BC; Kihlberg J
Curr Opin Chem Biol; 2018 Jun; 44():23-29. PubMed ID: 29803972
[TBL] [Abstract][Full Text] [Related]
13. Impact of Dynamically Exposed Polarity on Permeability and Solubility of Chameleonic Drugs Beyond the Rule of 5.
Rossi Sebastiano M; Doak BC; Backlund M; Poongavanam V; Over B; Ermondi G; Caron G; Matsson P; Kihlberg J
J Med Chem; 2018 May; 61(9):4189-4202. PubMed ID: 29608068
[TBL] [Abstract][Full Text] [Related]
14. Conformational Sampling of Macrocyclic Drugs in Different Environments: Can We Find the Relevant Conformations?
Poongavanam V; Danelius E; Peintner S; Alcaraz L; Caron G; Cummings MD; Wlodek S; Erdelyi M; Hawkins PCD; Ermondi G; Kihlberg J
ACS Omega; 2018 Sep; 3(9):11742-11757. PubMed ID: 30320271
[TBL] [Abstract][Full Text] [Related]
15. Flexibility in early drug discovery: focus on the beyond-Rule-of-5 chemical space.
Caron G; Digiesi V; Solaro S; Ermondi G
Drug Discov Today; 2020 Apr; 25(4):621-627. PubMed ID: 31991117
[TBL] [Abstract][Full Text] [Related]
16. Going Viral: An Investigation into the Chameleonic Behaviour of Antiviral Compounds.
Wieske LHE; Atilaw Y; Poongavanam V; Erdélyi M; Kihlberg J
Chemistry; 2023 Feb; 29(8):e202202798. PubMed ID: 36286339
[TBL] [Abstract][Full Text] [Related]
17. Can small drugs predict the intrinsic aqueous solubility of 'beyond Rule of 5' big drugs?
Avdeef A; Kansy M
ADMET DMPK; 2020; 8(3):180-206. PubMed ID: 35300304
[TBL] [Abstract][Full Text] [Related]
18. Rifampicin as an example of beyond-rule-of-5 compound: Ionization beyond water and lipophilicity beyond octanol/water.
Ermondi G; Vallaro M; Saame J; Toom L; Leito I; Ruiz R; Caron G
Eur J Pharm Sci; 2021 Jun; 161():105802. PubMed ID: 33716188
[TBL] [Abstract][Full Text] [Related]
19. Drug Syntheses Beyond the Rule of 5.
Tyagi M; Begnini F; Poongavanam V; Doak BC; Kihlberg J
Chemistry; 2020 Jan; 26(1):49-88. PubMed ID: 31483909
[TBL] [Abstract][Full Text] [Related]
20. "Flexible-Acceptor" General Solubility Equation for beyond Rule of 5 Drugs.
Avdeef A; Kansy M
Mol Pharm; 2020 Oct; 17(10):3930-3940. PubMed ID: 32787270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
